Previous Article | Next Article ![]()
Journal of Bacteriology, October 2004, p. 6782-6791, Vol. 186, No. 20
0021-9193/04/$08.00+0 DOI: 10.1128/JB.186.20.6782-6791.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
Mark S. Johnson, Alexandre V. Repik,
and Barry L. Taylor*
Division of Microbiology and Molecular Genetics, Loma Linda University, Loma Linda, California
Received 17 May 2004/ Accepted 19 July 2004
|
|
|---|
|
|
|---|
We are interested in PAS sensing and signaling in Aer, an FAD-containing aerotaxis receptor in Escherichia coli (6, 7, 35, 36). Aerotaxis is a rapid behavioral response to an oxygen gradient that guides cells to a region where the oxygen concentration is optimal for growth of the species (42, 43, 45). The Aer protein has an N-terminal PAS domain, an F1 segment, a 38-amino-acid hydrophobic sequence, a HAMP domain, and a C-terminal signaling domain (6, 36) (Fig. 1). The HAMP domain and highly conserved signaling region are common to all bacterial chemoreceptors, whereas the PAS domain and extended hydrophobic region are unique to Aer (7, 35). Residues essential for FAD binding have been identified in the PAS, F1, and HAMP domains, but it has not been established whether the essential F1 and HAMP residues bind to the FAD molecule or maintain the protein conformation for FAD binding (6, 36). The crystal structure of the LOV2 domain from the Adiantum phytochrome-phototropin chimeric photoreceptor, Phy3, was recently solved, and the FMN cofactor is bound within a pocket in the PAS domain (17). By analogy to phototropin and the established role of bound cofactors in the FixL and photoactive yellow protein (PYP) PAS domains, it is likely that the isoalloxazine ring of FAD binds within the PAS domain. However, the Phy3 structure cannot be used as a model to infer whether the adenine group of FAD also binds within the PAS domain. The adenine moiety might associate with the F1 region, the HAMP domain or, considering the labile nature of FAD binding, extrude into the cytosol.
![]() View larger version (33K): [in a new window] |
FIG. 1. Cartoon of dimeric Aer and Tsr proteins. The periplasmic and cytosolic structures of Tar and Tsr, respectively, have been resolved by X-ray crystallography (12, 24). The cytosolic domains of two monomers form a four-helix bundle, with distal "U-turns" comprised of a highly conserved sequence that signals to the chemotactic machinery. The structure of the HAMP domain has not been resolved. Its topology has been predicted from cysteine scanning of the Tar receptor (9). The PAS domain of Aer was modeled as described earlier (36). The F1 region (6) and HAMP domain (5) of Aer were modeled from their predicted secondary structures (PSIPRED [http://insulin.brunel.ac.uk/psipred/]). The membrane binding region was predicted from hydropathy plots generated by the dense alignment surface method (DAS) (http://www.sbc.su.se/%7Emiklos/DAS/) and the C terminus was modeled from the predicted secondary structure as well as from the resolved X-ray crystal structure of the C-terminal region of Tsr (24).
|
The typical chemoreceptor, such as Tar or Tsr (Fig. 1), has a periplasmic sensing and cytoplasmic signaling domain. The binding of aspartate to the periplasmic domain of Tar causes a conformational change that moves the
4 helix toward the cytoplasm (11, 31). The movement of the
4 helix is transmitted to the cytoplasmic signaling domain by a helix that links
4 to the second transmembrane helix and the HAMP domain. In the Aer protein, where the N-terminal and C-terminal domains are cytosolic (Fig. 1), the signal from the FAD-PAS domain could be transmitted through the transmembrane helices or by direct interaction between the PAS domain and the C-terminal domain. In the course of investigating anomalous properties of truncated fragments of the Aer protein during purification, we determined that the membrane and/or HAMP domain sequences are essential for correct folding of the Aer PAS domain and, possibly, the F1 region.
|
|
|---|
Bacterial strains.
E. coli XL1-Blue (Stratagene) and BL21(DE3) (Novagen, Madison, Wis.) were used for cloning and expression of constructs, respectively. BL21(DE3) is deficient in the OmpT and Lon proteases and contains a
prophage that carries the T7 RNA polymerase gene. Isogenic strains UU1117 (aer [7]), RP5882 (tsr [10]) and BT3312 (aer tsr [36]) are derivatives of the E. coli K-12 RP437 strain (32).
Plasmids. The plasmid pT-GroE has a chloramphenicol marker and expresses GroES and GroEL under the control of the T7 promoter (kindly provided by the Burnham Institute in San Diego [49]). The parental plasmids for Aer were pGH1 and pAVR2. Both are isopropyl-D-thiogalactopyranoside (IPTG)-inducible trc expression vectors containing the aer gene, but pAVR2 contains an N-terminal His6 tag (2, 35, 36). Plasmid pGH5 (codons 1 to 166) was constructed by high-fidelity PCR synthesis (primers: sense, 5'-CCCTGGCGCCCAATACGCAAAC-3'; antisense, 5'GCTCTAGACTAACGCGCCCGCCAGCGAAGCG-3') from the pGH1 plasmid and subcloned into the KasI and XbaI site of vector pTrc99a. Plasmids pAVR66 (codons 20 to 119; sense, 5'-CCCCCGGCGCCCTGATGTCCACTACCGATCTG-3'; antisense, 5'-CCCCCAAGCTTCTACGTCGCCCGGGTACGAATCG-3') and pAVR67 (codons 20 to 131; sense, 5'-CCCCCGGCGCCCTGATGTCCACTACCGATCTG-3'; antisense, 5'-CCCCCAAGCTTCTATTTGTACAGCGGCTCCACCG-3') were constructed by high-fidelity PCR synthesis from the pGH1 plasmid and subcloned into the EheI-HindIII sites of the pTrc99a expression vector.
The parental plasmid for the His6-tagged Aer constructs was pAVR2, a His6-tagged, IPTG-inducible trc expression vector containing the aer gene (36). Plasmid pAVR63 (including aer codons 2 to 146) was constructed by using PCR (primers: sense, 5'-CCAGGCGCCTCTTCTCATCCGTATGTC-3'; antisense, 5'-CTCGTCGACCTAAGGCCTTTATGAATACGC-3') to introduce a stop codon and XbaI restriction site after codon 146, and an EheI-XbaI fragment containing codons 2 to 146 of aer was subcloned into the pProEX HTa expression vector (Gibco BRL, Life Technologies, Gaithersburg, Md.). Plasmids pAVR64 (codons 20 to 119) and pAVR65 (codons 20 to 131) were constructed as described for pAVR66 and pAVR67, except PCR products were cloned into the pProEX HTa expression vector. Plasmids pQH7 (codons 2 to 231; sense, 5'-AGCGGATAACAATTTCACACAGGA-3'; antisense, 5'-AAAACTGCAGTTACTCAACACTATTACGTTCTCCGGTCGCCAC-3') and pQH10 (codons 2 to 285; sense, 5'-AGCGGATAACAATTTCACACAGGA-3'; antisense, 5'-AAACTGCAGTTAGGTATGTTCGTTCAGTTCATC-3') were similarly constructed by PCR and subcloned into the EheI-PstI sites of pProEX HTa. Plasmid pQH8 (codons 209 to 285; sense, 5'-GCAAGGCCTGTGCGCCCGATAGAAAAT-3'; antisense, 5'-AAACTGCAGTTAGGTATGTTCGTTCAGTTCATC-3') was constructed by cloning a StuI-PstI-digested PCR fragment into the EheI-PstI sites of pProEX HTa. Plasmid pAVR1 (codons 2 to 166) was described earlier (36). All constructs (Fig. 2) were confirmed by sequencing the entire coding region of Aer. Table 1 summarizes the relevant properties of strains and plasmids used in this study.
![]() View larger version (31K): [in a new window] |
FIG. 2. Predicted domain structure of truncated Aer constructs used for folding and FAD binding studies. The relative positions of amino acid residues referenced in the text are indicated on a scale at the bottom of the figure. Abbreviations: N-cap, N-terminal cap of the PAS domain (27); TM, hydrophobic sequence predicted to cross the membrane twice.
|
|
View this table: [in a new window] |
TABLE 1. Strains and plasmids
|
Fractionation of cell extract. E. coli BL21(DE3) cells were transformed with plasmids expressing the appropriate Aer fragments and grown at 30°C to mid-log phase (optical density at 600 nm [OD600] = 0.4 to 0.6) in 250 ml of Luria-Bertani medium containing thiamine (l µM) and ampicillin (100 µg ml1). IPTG was added to a final concentration of 1 mM, and the cells were grown for an additional 3 h to induce peptide synthesis. Cells were pelleted at 9,000 x g for 15 min, resuspended in 13 ml of lysis buffer (10 mM sodium phosphate [pH 7.5], 300 mM NaCl, 10% [wt/vol] glycerol), and lysed by seven passes through a French press at 10,000 lb/in2. Cellular debris and inclusion bodies were removed by centrifugation at 12,000 x g for 30 min. The membranes were pelleted by centrifugation at 485,000 x g for 30 min. Both the membrane fraction and soluble high-speed supernatant were stored at 20°C for up to 1 month.
HPLC. A 100-µl aliquot of high-speed supernatant, prefiltered through a 0.2-µm microfilterfuge tube (nylon-66; Rainin Instrument Co., Emeryville, Calif.), was injected onto a size-exclusion high-performance liquid chromatography (HPLC) column (Supelco TSK-Gel; G-2000SW or G-4000SW) and eluted with buffer (10 mM sodium phosphate [pH 7.0], 300 mM NaCl, 10% [wt/vol] glycerol, and 0.02% sodium azide) at a flow rate of 1 ml min1. Fractions were collected every minute and analyzed in a Western blot assay using rabbit sera raised against the His6-Aer2-166 peptide. When samples contained detergent, 0.02% n-dodecyl-maltoside was included in the mobile phase.
Purification of the His6-Aer2-166 complex. Twelve milliliters of the high-speed supernatant from BL21(DE3)/pAVR1 (9 mg of protein ml1; 108 mg of total protein) was loaded onto a Sephadex G-200 or Sephacryl 500-S-HR column (95 by 2 cm) and developed with 10 mM potassium phosphate buffer (pH 7.5) at a flow rate of 0.28 ml min1. Fractions (100 drops) were collected and analyzed by Western blotting. The peak fraction containing His6-Aer2-166 was applied to 15 lanes of a native mini-gel and electrophoresed. One lane was cut out for Western blotting; the remaining 14 lanes were stained with Coomassie brilliant blue. One prominent band near the top of the gel was evident. His6-Aer2-166 comigrated with this prominent band, as identified by Western blotting. Subsequently, the band was excised from the 14 lanes and loaded into one well of a denaturing sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) gel for denaturing electrophoresis.
Detergent extraction of Aer fragments from membranes. Membranes from E. coli BL21(DE3) cells transformed with pAVR1, pQH7, and pQH10 were prepared as described above in "Fractionation of cell extract, " except that cell debris and inclusion bodies were removed by centrifugation at 12,000 x g for 1.5 h rather than for 30 min. Membranes were resuspended in 50 mM Tris (pH 8.1) at 4°C with HCl, 300 mM NaCl, 10% glycerol, and 2% Triton X-100 by sonication at 20% power for 15 s and incubated on ice for 15 min. Samples were recentrifuged at 485,000 x g for 30 min, and the pellet was resuspended by sonication in the same buffer. This process was repeated twice more to yield four sequential membrane extractions with detergent. Aliquots from the pellets and supernatant fractions of each step were transferred to SDS sample buffer for SDS-PAGE and Western blotting.
Detergent-dependent release of the His6-Aer2-166 fragment from GroEL. Five hundred milliliters of BL21(DE3) cells transformed with pAVR1 was grown to an OD600 of 0.6, induced with 1 mM IPTG for 3 h, harvested at 8,000 x g for 15 min, resuspended in 12 ml of buffer (10 mM potassium phosphate [pH 7.0], 300 mM NaCl, 10% [wt/vol] glycerol), and lysed by seven passes through a French pressure cell (10,000 lb/in2). Cellular debris and inclusion bodies were removed by six sequential centrifugations at 12,000 x g for 20 min (discarding the pellet each time) until no pellet was visible. The final supernatant was then centrifuged at 485,000 x g for 30 min, and this final supernatant, if not used immediately, was aliquoted and frozen at 20°C for up to 1 month. Five hundred-microliter aliquots of the high-spin supernatant containing 3.5 mg of protein were incubated for 30 min with 0.25, 0.5, 0.75, or 1% SDS, 1 or 2% n-dodecyl-maltoside, or 1, 2, 3, 4, or 5% Triton X-100. Separation of His6-Aer2-166 from GroEL was assayed by HPLC size-exclusion chromatography as described above and by adsorption to a nickel resin, which presumably required separation from GroEL to bind the His6 tag. For nickel binding assays, 200 µl of nickel resin was prewashed three times in 1 ml of 50 mM Tris (pH 8.0) at 4°C with HCl, 300 mM NaCl, 10% glycerol, and a detergent concentration matching that used during the extraction of the specific high-spin supernatant. Samples and resin were incubated at 4°C for 30 min in a microcentrifuge tube. The unadsorbed fraction, washes, and elutions were separated from the resin by centrifugation for 1 min at 10,000 x g. After removing the unadsorbed fraction, the resin was washed three times with 1-ml aliquots of the same buffer, and the adsorbed proteins were eluted three times with 200-µl aliquots of 300 mM imidazole in the same buffer. His6-Aer2-166 was identified by Western blotting after SDS-PAGE.
ATP-dependent release of Aer fragments from GroEL. ATP (5 mM) and MgCl2 (20 mM) were added to the soluble fraction of His6-Aer2-166 overexpressed in E. coli BL21(DE3). After 15 min, the sample was injected onto a gel filtration HPLC column and fractions were collected and analyzed using a Western blot to identify His6-Aer2-166.
Coexpression of His6-Aer2-166 and His6-Aer209-285. Plasmids pAVR1 and pQH13 were transformed via heat shock into strain BT3312. One colony was grown overnight, subcultured, and grown to mid-log phase in Luria-Bertani medium supplemented with thiamine (1 µM), ampicillin (100 µg ml1), and chloramphenicol (50 µg ml1) before inducing for 3 h with 1 mM IPTG. After harvesting, cell pellets were suspended in 50 mM Tris (pH 8.0 with HCl at 4°C), 300 mM NaCl, and 10% (wt/vol) glycerol and lysed by five freeze-thaw cycles in lysozyme (0.1 mg ml1) followed by two sonication cycles for 30 s at 50% power. The cell extract was centrifuged at 12,000 x g for 30 min, and the resulting supernatant was centrifuged at 485,000 x g for 30 min. Samples were separated by SDS-PAGE, and the Aer fragments were identified by Western blotting using the INDIA HisProbe-HRP (1:10,000 dilution), as opposed to His6-Aer2-166 antiserum, which does not recognize His6-Aer209-285. After washing off the unbound INDIA HisProbe (containing HRP-conjugated nickel), the SuperSignal chemiluminescent substrate was immediately added without the need of secondary antibodies.
FAD binding measurements. FAD binding to the Aer protein was inferred by measuring the increase in membrane FAD when Aer was overproduced as described previously (7, 36). Direct association of FAD and His6-Aer2-285 was confirmed by the visible absorbance maxima of the nickel-purified protein, which showed peaks at approximately 450 nm (free FAD) and 470 nm (presumably His6-Aer2-285-FAD), similar to that reported for the full construct (6). A heme contaminant that absorbed at 420 nm was removed with three 1-ml washes containing 5 mM histidine, and His6-Aer2-285-FAD was eluted with four 100-µl washes containing 100 mM histidine. The FAD cofactor was identified by HPLC after extracting it from the purified protein in 8 M urea as previously described (36).
Behavioral assays. E. coli RP5882 cells transformed with pQH8 (His6-Aer209-285) were grown at 30°C in Luria-Bertani medium supplemented with thiamine (0.5 µg ml1) and ampicillin (100 µg ml1) to an OD600 of 0.20 to 0.25. IPTG was added to a final concentration of 1 mM, and the cells were grown until the OD600 was 0.40 to 0.45. Aerotactic responses were quantitated with a temporal assay as described previously (26). Chemotaxis to serine and aspartate was determined in a tryptone swarm plate assay (1).
|
|
|---|
![]() View larger version (33K): [in a new window] |
FIG. 3. Western blot showing typical partitioning of Aer fragments into soluble and insoluble fractions when cooverexpressed with GroEL. BL21(DE3) cells transformed with GroEL (pT-GroE) and Aer peptide fragments were grown in Luria broth supplemented with thiamine (1 µM), ampicillin (100 µg/ml), and chloramphenicol (25 µg/ml) to mid-log phase (OD600 = 0.4 to 0.5), induced with 1 mM IPTG for 3 h, pelleted, suspended in buffer with 0.3 mg of lysozyme/ml, freeze-thawed five times, and sonicated with three 30-s pulses at 70% power and centrifuged at 20,800 x g for 15 min. The Aer peptides present in the pellet and supernatant fractions were separated by SDS-PAGE and identified by Western blotting as described in Materials and Methods. (A) Supernatant, "soluble " fractions. Lanes: 1, Aer20-131; 2, Aer20-131-His6; 3, Aer20-119-His6; 4, Aer2-166-His6. Mw, molecular weight standards. (B) Pellet, "insoluble" fractions. Lanes: 1, Aer20-131; 2, Aer20-131-His6; 3, Aer20-119-His6; 4, Aer2-166-His6.
|
100,000 Da) at the void volume (data not shown). When chromatographed through resins with a larger pore size, this putative PAS complex eluted at the void volume in a Sephadex G-200 column and at a fraction representing a molecular weight of
800,000 in a Sepharose 500-S-HR column (Fig. 5A and B).
![]() View larger version (17K): [in a new window] |
FIG. 4. Soluble His6-Aer2-166 binds poorly to nickel resin in the absence of detergent. The supernatant of the high-speed centrifugation of the extract from BL21(DE3)/pAVR1 cells overexpressing the His6-Aer2-166 peptide was prepared, and an aliquot was adsorbed to Ni-NTA agarose and eluted as described in Materials and Methods, with or without 1% n-dodecyl-maltoside. Fractions were separated by SDS-PAGE, and Aer peptides were identified by Western blotting as described in the legend to Fig. 3. (A) Without detergent. Lanes: 1, supernatant before adsorption to resin; 2, fraction that did not adsorb to resin; 3, first wash; 4, second wash; 5, eluate from first elution; 6, second eluate; 7, third eluate. (B) With 1% n-dodecyl-maltoside. Lanes: 1, fraction that did not adsorb to resin; 2, first wash; 3, second wash; 4, first eluate; 5, second eluate; 6, third eluate. Mw, molecular weight standards.
|
![]() View larger version (30K): [in a new window] |
FIG. 5. The His6-Aer2-166 and Aer2-166 peptides elute as high-molecular-weight complexes from gel filtration columns. The high-speed supernatant containing His6-Aer2-166 or Aer1-166 was prepared as described in the legend to Fig. 4. (A and B) Western blot and chromatographic profile of His6-Aer2-166 fractionated on a Sephacryl 500-S-HR column as described in Materials and Methods. Twelve milliliters of high-spin supernatant was applied to the column, and fractions (100 drops) were collected and analyzed by SDS-PAGE and by Western blotting as described in the legend to Fig. 3. These fractions (both panels) were used for further purification. (C and D) Western blots and a typical chromatographic profile of His6-Aer2-166 and Aer2-166 peptides fractionated by HPLC on a TSK-Gel G-4000SW size-exclusion column. One hundred microliters of high-spin supernatant was injected in the column, and 1-ml fractions were collected and analyzed. Both columns were calibrated using a molecular weight marker kit (GF-1000; Sigma).
|
![]() View larger version (56K): [in a new window] |
FIG. 6. Identification of GroEL as the major component in the Aer complex. The Aer complex shown in Fig. 5A (fraction 29) was electrophoresed by PAGE under nondenaturing conditions, and the band containing the complex was excised and transferred to a denaturing SDS-PAGE gel as described in Materials and Methods. The 68-kDa band was excised and identified by N-terminal sequencing as GroEL. Both gels shown were stained with Coommassie blue. The His6-Aer2-166 band was confirmed by Western blotting with purified antisera against His6-Aer2-166. Two other unidentified low-molecular-weight proteins were also extracted from the GroEL band. Abbreviations: Mw, molecular weight standards; WB, Western blot.
|
Sequence essential for PAS domain folding.
We examined Aer peptide fragments of varying lengths to identify the domains of Aer that are essential for releasing the PAS domain from GroEL (Fig. 2). Fragments His6-Aer20-119 and His6-Aer20-131 lacked the highly variable and flexible PAS N-terminal Cap (15), which is not required for folding of the PYP-PAS domain (47). His6-Aer2-146 included the entire PAS domain as well as
25 residues from the F1 region. The fraction of these His6-tagged fragments that was partitioned into the soluble fraction failed to bind well to a Ni2+ or Co2+ column and chromatographed as a large complex on HPLC size-exclusion chromatography, indicating that they, like His6-Aer2-166, were bound to GroEL (data not shown). When overexpressed, His6-Aer2-231, which includes the membrane binding region (residues 167 to 204) and part of the HAMP domain (residues 205 to 253), and His6-Aer2-285, which includes the entire HAMP domain (Fig. 1 and 2), were present in the membrane fraction, inclusion bodies, and to some extent in the soluble fraction. These fragments could be extracted from the membrane fraction with 1% Triton X-100 [Fig. 7A, lanes 4, 5, 7, and 9; results were similar in BL21(DE3) cells (shown) and XL1-blue and BT3312 cells (data not shown)]. The fragment His6-Aer2-166 was also present in the membrane fraction, but it was not extracted by this method (Fig. 7A, lanes 1 and 2). Therefore, it is likely that this fraction contained inclusion bodies of His6-Aer2-166 that had not pelleted at 12,000 x g. In the absence of detergent, a portion of His6-Aer2-231 and His6-Aer2-285 failed to pellet at 485,000 x g for 30 min (e.g., Fig. 7A, lane 6). This suggests that these peptides complex with GroEL, as did the shorter peptides that lack the membrane binding sequence. However, since His6-Aer2-231 and His6-Aer2-285 could be extracted from this membrane fraction with mild detergent, they were not irreversibly bound to GroEL and had inserted into the membrane. Of these two membrane-bound fragments, we observed no significant increase in bound FAD when His6-Aer2-231 was overexpressed, indicating that His6-Aer2-231 did not bind FAD. When His6-Aer2-285 was overexpressed from pQH10 in strain BT3312 by the addition of 1 mM IPTG, there was a 20-fold increase in membrane-bound FAD, indicating that His6-Aer2-285 bound FAD at levels similar to those with holo-Aer. When His6-Aer2-285 was purified on a nickel resin, it exhibited two prominent absorption maxima in the visible region at 447 and 470 nm (Fig. 7B), similar to that reported previously for Aer-FAD (6). Although not yet confirmed, the 447- and 470-nm peaks likely represent the free and bound forms of FAD, respectively (6). The identification of the FAD cofactor was confirmed by HPLC after extracting it from purified His6-Aer2-285 in 8 M urea (data not shown). These results suggest that FAD binding requires the region of the HAMP domain that includes residues between 231 and 285.
![]() View larger version (40K): [in a new window] |
FIG. 7. Western blot showing detergent solubilization of membrane-bound His6-Aer2-231 and His6-Aer2-285, but not membrane-bound His6-Aer2-166. (A) Membrane fractions of BL21(DE3) cells containing Aer peptide fragments were isolated, extracted, and reextracted four times with 1% Triton X-100 before Western blotting as described in Materials and Methods. Mw, molecular weight standards. Lanes: 1, membrane fraction from BL21(DE3)/pAVR1 cells expressing His6-Aer2-166 before adding detergent (lower band is a proteolytic product); 2, high-spin supernatant from sample in lane 1 after incubating for 30 min with 1% Triton X-100 and centrifuging; 3, membrane fraction from BL21(DE3)/pQH10 cells expressing His6-Aer2-285 before adding detergent; 4, high-spin supernatant from sample in lane 3 after incubating for 30 min with 1% Triton X-100 and centrifuging; 5, high-spin supernatant after reextracting pellet (produced by lane 4) with 1% detergent and recentrifuging; 6, high-spin supernatant of BL21(DE3)/pQH7 cells expressing Aer2-231 before adding detergent; 7, high-spin supernatant from sample in lane 8 after incubating for 30 min with 1% Triton X-100 and centrifuging; 8, membrane fraction from BL21(DE3)/pQH7 cells expressing His6-Aer2-231 before adding detergent; 9, high-spin supernatant after reextracting pellet (produced by lane 6) with 1% detergent and recentrifuging. (B) Purification and visible absorbance spectrum of His6-Aer2-285. Membranes containing His6-Aer2-285 were solubilized and purified on a nickel resin as described in Materials and Methods. The purity of individual fractions is shown in the SDS-PAGE gel, which was stained with Coommassie blue. Lanes: 1, molecular weight standards; 2, unadsorbed fraction; 3, first wash with 5 mM histidine; 4, second wash; 5, third wash; 6, first elution with 100 mM histidine; 7, second elution; 8, third elution; 9, fourth elution. The visible absorption spectrum of the elution from lane 6 is shown to the left of the gel.
|
800,000 Da, similar to that shown for Aer1-166 and His6-Aer2-166 in Fig. 5C and D. This indicated that the association of these N-terminal peptides with GroEL was independent of the His6 tag. Overexpression of the Aer HAMP domain fragment. Considering that inclusion of the HAMP domain enabled native folding of the PAS domain and FAD binding, it was possible that folding was stabilized by peptide-peptide interactions between the PAS and HAMP domains. We hypothesized that if such interactions occurred, they would also be involved in signaling between the N-terminal and C-terminal domains. To investigate this, His6-Aer209-285, which encodes the HAMP domain, was expressed from pQH8 in strain RP5882 (aer+ tsr-deficient). When expression was induced with 1 mM IPTG, the cells exhibited diminished responses to an increase or decrease in oxygen concentration. The magnitude of the responses was approximately 60% of that observed for the same strain without induction or for control strains lacking the His6-Aer209-285 construct (Table 2). This result suggested that the overexpressed Aer HAMP domain fragment competes with the HAMP domain of wild-type Aer in protein-protein interactions. This could be HAMP-PAS interactions, as hypothesized, but could also be HAMP-HAMP interactions within the Aer dimer.
|
View this table: [in a new window] |
TABLE 2. Effect of overexpressing His6-Aer209-285 on aerotaxis activitya
|
To determine whether the His6-Aer209-285 fragment could complement proper folding of the His6-Aer2-166 construct, pQH8 and pAVR1 were cotransformed into BL21(DE3) cells and coexpressed. His6-Aer209-285 distributed primarily into the soluble fraction, but little of His6-Aer2-166 partitioned into the soluble fraction (Fig. 8). When the soluble extracts were separated by size-exclusion HPLC, His6-Aer2-166 eluted as a large complex, whereas the His6-HAMP209-285 construct eluted as a low-molecular-weight species (data not shown). There was no evidence of an association between the two peptide fragments and no evidence that the HAMP fragment could complement native folding of the PAS domain in His6-Aer2-166.
![]() View larger version (40K): [in a new window] |
FIG. 8. Western blot of fractionated samples containing His6-Aer2-166 and His6-Aer 209-285 fragments, which were coexpressed in BT3312 cells. Mw, molecular weight standards. Lanes: 1, whole-cell extract; 2, low-spin supernatant; 3, high-spin supernatant; 4, high-spin pellet, including membrane fraction and inclusion bodies incompletely pelleted during low spin. The blot was visualized using the INDIA probe as described in Materials and Methods.
|
|
|
|---|
167 to 204) and part of the HAMP domain (residues 205 to 231) were included in the peptide, it was released from GroEL and inserted into the membrane. However, FAD binding required an additional segment of the HAMP domain located between residues 231 and 285. It is evident that amino acid residues in the HAMP domain of Aer stabilize FAD binding to the N terminus. This supports former studies showing that the point mutations R235C, E238K, and L249F in the HAMP domain of Aer abolished aerotaxis and destabilized FAD binding (6, 29, 36). Residues Y130 and L161 within the F1 region are also important for FAD binding (6). Previous mutagenesis of the Aer PAS domain, combined with the established cofactor binding properties of the PAS superfamily, suggests that FAD binds to the PAS domain of the N terminus (6, 29, 36). An important conclusion from this investigation is that residues outside the PAS domain are required to stabilize the native conformation of the PAS domain. It is possible that the F1 and HAMP residues that are essential for FAD binding stabilize the conformation of the PAS fold.
![]() View larger version (34K): [in a new window] |
FIG. 9. Cartoon summarizing the data, showing Aer fragments that formed a stable complex with GroEL and those that were released from GroEL. Initial complexation of GroEL and the His6-Aer2-231 and His6-Aer2-285 fragments was inferred by the presence of each in the soluble fraction (see e.g., Fig. 7A, lane 6). Fragments that included the membrane binding region and part of the HAMP domain were released from GroEL. FAD binding required a complete HAMP domain.
|
Peptides that included the membrane binding domain and part (His6-Aer2-231) or all (His6-Aer2-285) of the HAMP domain inserted into the membrane in a form that was readily extractable with mild detergent, indicating that they had not folded into insoluble aggregates or precipitates. Since a small fraction of these membrane-bound Aer fragments were also found in the soluble fraction, they may also be folded by GroEL prior to membrane insertion.
Inclusion bodies would be expected when protein overexpression overwhelms the GroEL pool and allows hydrophobic moieties from one monomer to associate with hydrophobic moieties from another monomer before folding is complete. However, we expected that a fraction of these peptides would be able to fold properly when GroES and GroEL were overexpressed (Fig. 3), since other PAS domains are soluble (13, 20, 22, 30, 33, 37). Furthermore, solubility was not improved when cells were grown at 15°C for 48 h at lower induction levels (IPTG, 0.05 mM). N-terminal Aer peptides appeared unable to fold properly with or without the His6 tag, the N-terminal cap (residues 1 to 19), or the F1 region. All formed a stable complex with GroEL, and this complex represented the entire soluble fraction of these peptides.
One possible interpretation of these results is that there is a direct association between residues in the N-terminal region and those in the membrane anchor and/or in the HAMP domain. In this scenario, N-terminal hydrophobic residues would be shielded from the solvent by residues in the membrane binding or HAMP regions. A similar interdomain structural dependency occurs in the lens protein
-crystallin, which precipitates into opaque cataracts, despite overexpression of chaperones when the N-terminal, NADPH-binding Rossman fold is deleted (19).
Another possibility is that FAD binding is required to stabilize proper PAS folding. Since the HAMP domain is required for FAD binding, a peptide without the HAMP domain would lose FAD and compromise the native PAS structure. Other apo-PAS domains have been shown to be unstructured in solution. The apo form of PYP is more accessible to deuterium exchange and prone to precipitation (23, 25), and the unliganded form of the PAS B domain of the aryl hydrocarbon receptor binds to hsp90 but can be displaced by certain aromatic compounds that bind to the cofactor binding pocket (14). Our data could not eliminate such a scenario for Aer. His6-Aer2-231 did not bind FAD, but it was released from GroEL and partitioned into the membrane fraction in a form that was readily solubilized by mild nonionic detergents. This indicates that His6-Aer2-231 did not fold into aggregates or inclusion bodies, but the data do not prove that His6-Aer2-231 folds into the native structure.
By itself, the HAMP domain was soluble and not associated with GroEL as judged by high-speed centrifugation and by size-exclusion HPLC. However, attempts to solubilize His6-Aer2-166 by coexpression with the His6-HAMP209-285 fragment failed.
Bibikov et al. (6) reported that the HAMP domain was required for FAD binding in Aer, and they included the possibility that this domain stabilizes the structure in the N terminus. Our data support this model and suggest that the HAMP domain may be required for proper folding of the N terminus. Inspection of a putative model of the Aer PAS domain (36) revealed six hydrophobic residues (Val-55, Met-56, Phe-71, Thr-82, Ile-83, and Val-93) that are potentially solvent accessible. Although it remains to be shown, these residues might contribute to precipitation of the PAS domain. In addition, a map of the electrostatic potential of the Aer PAS domain shows a strongly basic patch that is not present in the soluble PAS domains of FixL, PYP, and HERG (A. Repik, M. Johnson, and B. Taylor, unpublished data). Whether this electrostatic potential also contributes to the unique folding requirements of the Aer PAS domain is currently under investigation.
This work was supported by grants from the National Institute of General Medical Sciences (GM29481) and Loma Linda University to B.L.T.
Present address: Dow Chemical Co., San Diego, CA 92122. ![]()
Present address: University of Massachusetts Medical School, Worcester, MA 01605-2324. ![]()
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»